ROYAL FREE LONDON NHS FOUNDATION TRUST – MIA(IMP) 11149
| Authorisation Number | UK MIA(IMP) 11149 |
| Category | MIA(IMP) |
| Holder | ROYAL FREE LONDON NHS FOUNDATION TRUST |
| Registered Address | ROYAL FREE LONDON NHS FOUNDATION TRUST, PHARMACY DEPARTMENT, THE ROYAL FREE HOSPITAL, POND STREET, LONDON, NW3 2QG, UNITED KINGDOM |
| Authorisation Date | Jun 25, 2026 |
| Legal Basis | InvestigationalPart 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 [SI 2004/1031] |
| Sites | 3 |
| Manufacturing Operations | 1.1 1.1.1 1.1.1.1 1.1.1.3 1.1.1.4 1.1.1.5 1.1.1.6 1.1.2 1.1.2.1 1.1.2.2 1.1.2.3 1.1.2.5 1.1.3 1.2 1.2.1 1.2.1.1 1.2.1.11 1.2.1.13 1.2.1.5 1.2.1.6 1.2.2 1.3 1.3.1 1.3.1.2 1.3.1.3 1.3.1.4 1.3.1.6 1.3.1.7 1.3.1.8 1.3.2 1.3.2.2 1.3.2.3 1.3.2.4 1.3.2.6 1.3.2.7 1.3.2.8 1.4 1.4.2 1.4.2.1 1.4.2.3 1.5 1.5.1 1.5.1.1 1.5.1.13 1.5.1.2 1.5.1.5 1.5.1.6 1.5.1.8 1.5.2 1.6 1.6.1 1.6.2 1.6.3 1.6.4 |
| Importation Operations | 2.1 2.1.1 2.1.3 2.1.4 2.2 2.2.1 2.2.1.1 2.2.1.2 2.2.2 2.2.3 2.2.3.3 2.2.3.4 2.3 2.3.1 2.3.2 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (3)
ROYAL FREE LONDON NHS FOUNDATION TRUST
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.1 — Large volume liquids
1.1.1.3 — Semi-solids
1.1.1.4 — Small volume liquids
1.1.2 — Terminally Sterilised (processing operations for the following dosage forms)
1.1.2.1 — Large volume liquids
1.1.2.2 — Semi-solids
1.1.2.3 — Small volume liquids
1.1.2.5 — Other terminally sterilised prepared products
1.1.3 — Batch certification
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.5 — Liquids for external use
1.2.1.6 — Liquids for internal use
1.2.1.11 — Semi-solids
1.2.1.13 — Tablets
1.2.2 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.2 — Immunological products
1.3.1.6 — Human or animal extracted products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.2 — Immunological products
1.3.2.6 — Human or animal extracted products
1.4 — Other investigational medicinal products or manufacturing activitiy
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.4.2.3 — Moist heat
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.2 — Capsules, soft shell
1.5.1.5 — Liquids for external use
1.5.1.6 — Liquids for internal use
1.5.1.8 — Other solid dosage forms
1.5.1.13 — Tablets
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
Importation
2.1 — Quality control testing of imported medicinal products
2.1.3 — Chemical/Physical
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.1.2 — Terminally sterilised
2.2.2 — Non-sterile products
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
CELL AND VECTOR INNOVATION CENTRE (CIVIC)
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.5 — Solids and implants
1.1.1.6 — Other aseptically prepared products
1.1.3 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.7 — Tissue Engineered Products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
1.3.2.7 — Tissue Engineered Products
1.5 — Packaging
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.1 — Microbiological: sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Importation
2.1 — Quality control testing of imported medicinal products
2.1.1 — Microbiological: sterility
2.1.4 — Biological
2.2 — Batch certification of imported medicinal products
2.2.3 — Biological medicinal products
2.2.3.3 — Cell therapy products
2.2.3.4 — Gene therapy products
2.3 — Other Importation Activities
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
ROYAL FREE LONDON NHS FOUNDATION TRUST
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.4 — Small volume liquids
1.1.1.6 — Other aseptically prepared products
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.2 — Immunological products
1.3.1.3 — Cell therapy products
1.3.1.4 — Gene therapy products
1.3.1.6 — Human or animal extracted products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.2 — Immunological products
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
1.3.2.6 — Human or animal extracted products
1.3.2.8 — Other biological medicinal products
1.4 — Other investigational medicinal products or manufacturing activitiy
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.6 — Liquids for internal use
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Content Preview
The source document is available on KeyPedia. Sign in to view.